You are using an older browser version. Please use a supported version for the best MSN experience.

Pfizer stock drops on phase 3 breast cancer drug results

CNBC's Meg Tirrell reports that pharmaceutical company Pfizer's stock is down after negative results on its breast cancer drug results.

UP NEXT

UP NEXT

Recent Videos

Featured Partners

image beaconimage beaconimage beacon